Table 3.
Post-hoc propensity analysis of the patients on ICS.
ICS propensity | COPD/asthma | Non-COPD/asthma | p-value* |
---|---|---|---|
Median (1st, 3rd quartile) | 0.427 (0.257, 0.594) | 0.263 (0.043, 0.480) | <0.0001 |
Wilcoxon signed rank test
Post-hoc propensity analysis of the patients on ICS.
ICS propensity | COPD/asthma | Non-COPD/asthma | p-value* |
---|---|---|---|
Median (1st, 3rd quartile) | 0.427 (0.257, 0.594) | 0.263 (0.043, 0.480) | <0.0001 |
Wilcoxon signed rank test